The Venture Codex Logo

The Venture Codex

Overview

Developing small molecule drugs for life-threatening diseases.

Total Raised

$172 M

Rounds

5

Links

Verticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical

Investment History

  1. Series C

    May 2020

    $53M

  2. Series C

    Aug 2017

    $67M

  3. Series B

    Feb 2016

    $9M

  4. Series B

    Nov 2015

    $41M

  5. Equity

    May 2010

    $3M

Team

Michael Grey

President & CEO

Pamela Wedel

VP of Clinical Operations

Carlos Sattler

SVP of Clinical Development

Kevin Holme

Senior Vice President of Development